Manmeet Singh Soni, Director, COO and CFO, on June 04, 2026, executed a purchase for 50,000 shares in Summit Therapeutics (SMMT) for $722,250. Following the Form 4 filing with the SEC, Soni has control over a total of 3,123,603 common shares of the company, with 3,123,603 shares held directly.
SEC Filing:
Joseph Gebbia, 10% Owner, Director, on June 01, 2026, sold 265,000 shares in Airbnb (ABNB) for $35,893,438. Following the Form 4 filing with the SEC, Gebbia has control over a total of 3,187,953 Class A common shares of the company, with 5,598 shares held directly and 3,182,355 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1559720/000119312526255845/xslF345X05/ownership.xml
Paul L Alpern, Vice President and General Counsel, on June 01, 2026, sold 12,502 shares in Arteris (AIP) for $450,286. Following the Form 4 filing with the SEC, Alpern has control over a total of 80,384 common shares of the company, with 80,384 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1667011/000188854226000006/xslF345X05/primarydocument.xml
D James Bidzos, Director, Executive Chairman, President, & CEO, on June 02, 2026, sold 3,300 shares in Verisign (VRSN) for $981,646. Following the Form 4 filing with the SEC, Bidzos has control over a total of 439,339 common shares of the company, with 439,339 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1014473/000120481626000012/xslF345X05/wk-form4_1780522285.xml